Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.

Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, Klosterkoetter J, Ruhrmann S.

Biol Psychiatry. 2008 Sep 1;64(5):376-84. doi: 10.1016/j.biopsych.2008.02.006.

PMID:
18395700
2.

Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia.

Quednow BB, Frommann I, Berning J, Kühn KU, Maier W, Wagner M.

Biol Psychiatry. 2008 Nov 1;64(9):766-73. doi: 10.1016/j.biopsych.2008.04.019.

PMID:
18514166
3.

P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.

Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R.

Biol Psychiatry. 2004 Apr 1;55(7):663-7.

PMID:
15038993
4.

Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects.

Rentzsch J, Jockers-Scherübl MC, Boutros NN, Gallinat J.

Int J Psychophysiol. 2008 Feb;67(2):81-90.

PMID:
18053603
5.

P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment.

Cadenhead KS, Light GA, Shafer KM, Braff DL.

Biol Psychiatry. 2005 Jun 15;57(12):1504-9.

PMID:
15953486
7.

Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.

Chen XS, Li CB, Smith RC, Xiao ZP, Wang JJ.

Psychiatry Res. 2011 Aug 15;188(3):327-33. doi: 10.1016/j.psychres.2010.12.009.

PMID:
21216472
8.

Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis.

Carroll CA, Kieffaber PD, Vohs JL, O'Donnell BF, Shekhar A, Hetrick WP.

Bipolar Disord. 2008 Nov;10(7):776-87. doi: 10.1111/j.1399-5618.2008.00622.x.

PMID:
19032709
9.

Antipsychotic effects on auditory sensory gating in schizophrenia patients.

Sánchez-Morla EM, Santos JL, Aparicio A, García-Jiménez MA, Villanueva C, Martínez-Vizcaíno V, Arango C.

Eur Neuropsychopharmacol. 2009 Dec;19(12):905-9. doi: 10.1016/j.euroneuro.2009.09.001.

PMID:
19833483
10.

Chronic effects of cannabis on sensory gating.

Broyd SJ, Greenwood LM, Croft RJ, Dalecki A, Todd J, Michie PT, Johnstone SJ, Solowij N.

Int J Psychophysiol. 2013 Sep;89(3):381-9. doi: 10.1016/j.ijpsycho.2013.04.015.

PMID:
23628289
11.

Comparison of midlatency auditory sensory gating at short and long interstimulus intervals.

Rentzsch J, de Castro AG, Neuhaus A, Jockers-Scherübl MC, Gallinat J.

Neuropsychobiology. 2008;58(1):11-8. doi: 10.1159/000154475.

PMID:
18781086
12.

MEG does not reveal impaired sensory gating in first-episode schizophrenia.

Bachmann S, Weisbrod M, Röhrig M, Schröder J, Thomas C, Scherg M, Rupp A.

Schizophr Res. 2010 Aug;121(1-3):131-8. doi: 10.1016/j.schres.2010.03.007.

PMID:
20447805
13.

P50 gating at acute and post-acute phases of first-episode schizophrenia.

Devrim-Uçok M, Keskin-Ergen HY, Uçok A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1952-6. doi: 10.1016/j.pnpbp.2008.09.018.

PMID:
18929611
14.

Impaired P50 suppression in fear extinction in obsessive-compulsive disorder.

Nanbu M, Kurayama T, Nakazawa K, Matsuzawa D, Komiya Z, Haraguchi T, Ogura H, Hashimoto T, Yoshida S, Iyo M, Shimizu E.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):317-22. doi: 10.1016/j.pnpbp.2009.12.005.

PMID:
20035817
15.

A follow-up study on features of sensory gating P50 in treatment-resistant depression patients.

Wang Y, Fang YR, Chen XS, Chen J, Wu ZG, Yuan CM, Yi ZH, Hong W, Zhang C, Cao L.

Chin Med J (Engl). 2009 Dec 20;122(24):2956-60.

PMID:
20137481
16.

Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.

Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M.

Psychiatry Res. 2004 May 30;126(3):203-15.

PMID:
15157747
17.

[Sensory gating of patients with first-episode schizophrenia].

Chen XS, Zhang MD, Wang HX, Lou CY, Wang JJ, Guo Q, Liu L, Gao CY, Liu P, Liu XW, Duan HJ, Guo FL, Liang JH, Chen C, Chen XW.

Zhonghua Yi Xue Za Zhi. 2005 Dec 28;85(49):3457-9. Chinese.

PMID:
16686059
18.

P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.

Oranje B, Aggernaes B, Rasmussen H, Ebdrup BH, Glenthøj BY.

Schizophr Bull. 2013 Mar;39(2):472-80. doi: 10.1093/schbul/sbr183.

19.

Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.

Hsieh MH, Shan JC, Huang WL, Cheng WC, Chiu MJ, Jaw FS, Hwu HG, Liu CC.

Schizophr Res. 2012 Sep;140(1-3):243-9. doi: 10.1016/j.schres.2012.06.021.

PMID:
22784684
20.

Gender differences in gating of the auditory evoked potential in normal subjects.

Hetrick WP, Sandman CA, Bunney WE Jr, Jin Y, Potkin SG, White MH.

Biol Psychiatry. 1996 Jan 1;39(1):51-8.

PMID:
8719126

Supplemental Content

Support Center